271 filings
Page 7 of 14
UPLOAD
3w5y7x9klt2r
10 Jan 18
Letter from SEC
12:00am
CORRESP
bl1ltm8u
3 Jan 18
Correspondence with SEC
12:00am
8-K
sg3bj dfchp0un
29 Dec 17
Medovex Corporation Converts IDE Submission to a Pre-Submission with Food and Drug Administration for its DenerveX System
12:00am
UPLOAD
e9f16w10 7q
18 Dec 17
Letter from SEC
12:00am
8-K
7kmoq2
20 Nov 17
Regulation FD Disclosure
12:00am
8-K
ekpwd7 bnzgzzo3l4
14 Nov 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
NT 10-Q
0nqej0j f6tnf
14 Nov 17
Notice of late quarterly filing
12:00am
8-K
38qkqmv4cltb uz
19 Oct 17
Submission of Matters to a Vote of Security Holders
12:00am
UPLOAD
c3yb 4vrfv
8 Sep 17
Letter from SEC
12:00am
8-K
atc za1s966hsf
29 Aug 17
Medovex Corporation Receives Regulatory Approval from Australia's Therapeutic Goods Administration (TGA) for its DenerveX System
12:00am
8-K
6aezau7a7a
21 Aug 17
Medovex Corporation Names Charlie Farrahar Chief Financial Officer
12:00am
8-K
s93w 22o8w2
9 Aug 17
Regulation FD Disclosure
12:00am